$3.80
-0.02[-0.52%]
At close: Apr 26
$3.80
0[0.00%]
After Hours: 4:20PM EDT
Akoya Biosciences
(NASDAQ:AKYA)Akoya Biosciences Stock (NASDAQ:AKYA), Insider Trading Activity
Akoya Biosciences: Insider buying and selling updated today.
Shares Outstanding
49.380M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | Brian McKelligon | PRESIDENT AND CEO | 0 | $2.63 | -$34.97K | SELL-OPTIONS | 0.00% | 231.868K | Mar 20 | View |
| Mar 14, 2024 | Brian McKelligon | PRESIDENT AND CEO | -7.5K | $4.94 | -$37.03K | SELL | -3.23% | 224.368K | Mar 13 | View |
| Dec 20, 2023 | Brian McKelligon | PRESIDENT AND CEO | 0 | $2.39 | -$31.29K | SELL-OPTIONS | 0.00% | 152.563K | Dec 19 | View |
| Dec 14, 2023 | Brian McKelligon | PRESIDENT AND CEO | 0 | $2.28 | -$29.60K | SELL-OPTIONS | 0.00% | 152.563K | Dec 12 | View |
| Nov 22, 2023 | Brian McKelligon | PRESIDENT AND CEO | 0 | $2.34 | -$30.63K | SELL-OPTIONS | 0.00% | 152.563K | Nov 20 | View |
| Sep 11, 2023 | Frederic Pla | CHIEF OPERATING OFFICER | 20K | $4.60 | $92.01K | BUY | 49.32% | 60.555K | Sep 07 | View |
| Jun 12, 2023 | John Frederick Ek | CFO | 20K | $5.00 | $100.00K | BUY | 12.50% | 180K | Jun 12 | View |
| Jun 12, 2023 | Myla Lai-Goldman | DIRECTOR | 20K | $5.00 | $100.00K | BUY | ∞ | 20K | Jun 12 | View |
| Jun 12, 2023 | Scott Mendel | DIRECTOR | 20K | $5.00 | $100.00K | BUY | 235.29% | 28.5K | Jun 12 | View |
| Jun 12, 2023 | Matthew Winkler | DIRECTOR | 203.388K | $5.00 | $1.02M | BUY | 26.04% | 984.513K | Jun 12 | View |
| Jun 12, 2023 | Robert G Shepler | DIRECTOR | 120K | $5.00 | $600.00K | BUY | 48.08% | 369.592K | Jun 12 | View |
| Jun 12, 2023 | Thomas A Raffin | DIRECTOR | 2.02M | $5.00 | $10.10M | BUY | 14.51% | 15.937535M | Jun 12 | View |
| Jun 06, 2023 | Brian McKelligon | PRESIDENT/CEO | 0 | $3.01 | -$27.02K | SELL-OPTIONS | 0.00% | 152.563K | Jun 06 | View |
| Mar 16, 2023 | Brian McKelligon | PRESIDENT/CEO | 0 | $4.74 | -$44.34K | SELL-OPTIONS | 0.00% | 160K | Mar 14 | View |
| Dec 20, 2022 | Thomas P Schnettler | DIRECTOR | -71.05K | $13.03 | -$925.78K | SELL | -2.53% | 2.742721M | Dec 13 | View |
| Dec 16, 2022 | Joseph Driscoll | CHIEF FINANCIAL OFFICER | 0 | $6.49 | -$297.88K | SELL-OPTIONS | 0.00% | 12.5K | Dec 14 | View |
| Dec 15, 2022 | Garry Nolan | DIRECTOR | -100 | $13.25 | -$1.32K | SELL | -0.02% | 555.084K | Dec 13 | View |
| Dec 08, 2022 | Brian McKelligon | PRESIDENT/CEO | 0 | $6.19 | -$58.90K | SELL-OPTIONS | 0.00% | 80K | Dec 06 | View |
| Dec 06, 2022 | Garry Nolan | DIRECTOR | -1.1K | $13.25 | -$14.57K | SELL | -0.19% | 591.978K | Dec 02 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.